加载中
NYSEHealthcareDrug Manufacturers - General
最新数据
US$141.98
−US$3.47 · -2.39%
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
收盘时
US$141.98
−US$3.47 · -2.39%
盘后
US$142
+US$0.02 · +0.01%
10月13日 16:29 ET
盘中时间采用ET。市场数据可能有所延迟。
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
日内区间
当前US$141.98
52周区间
当前US$141.98
盘中时间采用ET。市场数据可能有所延迟。
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
日内区间
当前US$141.98
52周区间
当前US$141.98
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$158.5
上涨空间 11.64%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2021年6月3日 | 131:125 | — | — |
股票拆分 | 1999年2月17日 | 2:1 | — | — |
股票拆分 | 1992年5月26日 | 3:1 | — | — |
股票拆分 | 1988年5月26日 | 3:1 | — | — |
股票拆分 | 1986年5月27日 | 2:1 | — | — |
股票拆分 | 1972年6月1日 | 2:1 | — | — |
已生效 2021年6月3日
131:125
已生效 1999年2月17日
2:1
已生效 1992年5月26日
3:1
已生效 1988年5月26日
3:1
已生效 1986年5月27日
2:1
已生效 1972年6月1日
2:1
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T6946.95亿0.53%130.34万亿 JPY0.09%JP¥122,950+0.08%
Vanguard Morningstar Total Stock Market ETFVTI115.99亿0.49%2.3万亿 USD0.03%US$381.32-0.07%
Vanguard S&P 500 ETFVOO96.94亿0.55%1.8万亿 USD0.03%US$715.14+0.00%
iShares Core S&P 500 ETFIVV47.74亿0.53%8964.4亿 USD0.03%US$781.42-0.00%
Schwab U.S. Dividend Equity ETFSCHD44.58亿4.01%1111.94亿 USD0.06%US$33.37+0.33%
State Street SPDR S&P 500 ETFSPY43.84亿0.53%8216.79亿 USD0.09%US$778.05-0.01%
Vanguard Morningstar Value ETFVTV34.88亿1.33%2624亿 USD0.03%US$220.67-0.34%
State Street Health Care Select Sector SPDR ETFXLV25.43亿5.74%443.1亿 USD0.08%US$169.66-1.35%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOiShares Core S&P 500 ETFIVVSchwab U.S. Dividend Equity ETFSCHDState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street Health Care Select Sector SPDR ETFXLVAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
